Moneycontrol PRO

you are here: HomeNewsEye on indiaVideosExplained | COVID-19: Gilead licensing agreement of Remdesivir

SHOW NAMES

X

eye-on-india

Explained | COVID-19: Gilead licensing agreement of Remdesivir

In this episode of the Explained series, understand what does the licensing agreements mean for the fight against COVID-19.

first published: May 15, 2020 10:46 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Nifty Struggles Below 26,100 On Weekly F&O Expiry As Rupee Hits New Low| Closing Bell Live
Will Rupee Slide & Expiry Day Caution Keep Nifty Bulls On The Back Foot? | Opening Bell Live
Sensex, Nifty Retreat After Hitting Fresh Highs As Rupee Drops To Record Low| Closing Bell Live
Will Solid Q2 GDP Set The Ball Rolling For Nifty Bulls To Cross 26,300 Decisively?|Opening Bell Live

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347